Recent Updates
Recently added Catalysts
OPK Positive Sentiment

OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

Tuesday, September 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: OPKO Health, Inc. will participate in the Wells Fargo 21st Annual Healthcare Conference on September 10, 2026. Key executives, including Dr. Elias A. Zerhouni and Adam Logal, will engage in a fireside chat. The event highlights OPKO's focus on serious diseases and its strategic positioning in the healthcare market.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a prominent healthcare conference
  • Opportunity for company leaders to engage with investors
  • Showcases OPKO's commitment to transparency and communication

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+33%
120-day peak, hindsight
Typical move
8.6%
average across 4 past catalysts
Cash runway
~20 mo
Low dilution risk
Lead asset
OPK-88003
Phase 2 · Type 2 Diabetes Mellitus

Full Press Release Details

MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that Elias A. Zerhouni, M.D., President and Vice Chairman, and Adam Logal, Senior Vice President and Chief Financial Officer, will participate in the Wells Fargo 21st Annual Healthcare Conference at the Encore Boston Harbor, including a fireside chat on Thursday, September 10, 2026, at 9:30 a.m. ET.
A webcast and replay of the fireside chat can be accessed from the OPKO IR website.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise, and novel and proprietary technologies. For more information, please visit www.opko.com.

Contacts: Alliance Advisors IR Vivian Cervantes, 973-873-7724 vcervantes@allianceadvisors.com

Frequently Asked Questions

When is OPKO Health participating in the conference?

OPKO Health will participate in the conference on September 10, 2026.

Who will represent OPKO Health at the conference?

Dr. Elias A. Zerhouni and Adam Logal will represent OPKO Health.

What type of event will OPKO participate in?

OPKO will participate in a fireside chat during the conference.

Where is the Wells Fargo Healthcare Conference held?

The conference will be held at the Encore Boston Harbor.

ShareAdd on Google
Tags: OPK Viatris Investor Conferences Healthcare OPKO Health Wells Fargo healthcare conference Elias Zerhouni biopharmaceuticals
Last updated: Sep 8, 2026

Biotech snapshot

Cash runway
$301M liquidity · $15M/mo burn
~20 mo
Low dilution risk
Lead asset
OPK-88003Phase 2
Type 2 Diabetes Mellitus →

Catalyst track record

+33%
best trade around OPK's most recent catalyst

Peak hindsight return over a 120-day window, across 4 tracked FDA/PDUFA catalysts for OPK.

See every catalyst's timing & PoA →